<DOC>
	<DOCNO>NCT00242359</DOCNO>
	<brief_summary>Management animal induce occupational asthma mainly avoidance , feasible many occupation . Treatment avoidance conventional treatment also always successful . Omalizumab FDA approve treatment allergic asthma may effective reduce symptom disease progression animal handler population .</brief_summary>
	<brief_title>A Pilot Study Investigating Effect Omalizumab ( Xolair ) Work-Related Animal Induced Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Omalizumab</mesh_term>
	<criteria>1. age 1865 2. occupation involve close contact animal 3. stable dose ICS 30 day 4 . Skin test positive one animal 5. evidence asthma spirometry 6. demonstrate PEFR variability 1. allergen immunotherapy 2. prohibit medication 3. unstable asthma 4. recent URI 5. know hypersensitivity omalizumab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>